Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pear Therapeutics, Inc.

https://peartherapeutics.com/

Latest From Pear Therapeutics, Inc.

Pear Therapeutics Plans To Accelerate Reimbursement For Digital Therapeutics With $80M Series D

The company will use the proceeds to market its three FDA-cleared prescription digital therapeutics.

Digital Health Financing

Pear Therapeutics Launches Digital Insomnia Telehealth App

The pandemic has led to a rise in sleep problems. Somryst seeks to address chronic insomnia by training the body and brain to fall asleep faster and stay asleep longer.

Digital Health Launches

BI Finds Right Fit For Digital Therapeutic Partnership With Click

Deal Snapshot: The firms are partnering on a digital therapeutic for schizophrenia in a deal potentially worth $500m. 

Digital Health Deals

Korea Plays Catch-Up In Digital Therapeutics

 

South Korea Digital Health
See All

Company Information

  • Industry
  • Digital Health
  • Medical Devices
  • Pharmaceuticals
UsernamePublicRestriction

Register